IC

IBS Capital

North America, Massachusetts, United States, Boston

Description

IBS Capital is an advisory and investment management company that provides hedge fund investment services.

Investor Profile

IBS Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Post Ipo Equity, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series C (25%)
  • Post Ipo Equity (25%)
  • Series A (25%)
  • Series Unknown (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Neuroscience
  • Pharmaceutical
  • Commercial
  • Manufacturing
  • Mineral
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does IBS Capital frequently co-invest with?

DRADS Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
C
North America, New York, United States, New York
Co-Investments: 1
Lineage Cell Therapeutics
North America, California, United States, Carlsbad
Co-Investments: 1
Spinnaker Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
KIZOO Technology Capital
Europe, Baden-Wurttemberg, Germany, Karlsruhe
Co-Investments: 1
Wexford Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1

Which angels does IBS Capital often collaborate with?

JM
North America, Texas, United States, Dallas
Shared Deals: 1
JM
Europe, Isle of Man
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by IBS Capital?

AZTherapies

Boston, Massachusetts, United States

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

BiopharmaBiotechnologyHealth CareNeurosciencePharmaceuticalTherapeutics
Series COct 17, 2019
Amount Raised: $26,300,000
AgeX Therapeutics

Alameda, California, United States

AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases.

BiotechnologyHealth CareTherapeutics
Series UnknownAug 2, 2017
Amount Raised: $10,000,000
AZTherapies

Boston, Massachusetts, United States

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

BiopharmaBiotechnologyHealth CareNeurosciencePharmaceuticalTherapeutics
Series ANov 20, 2015
Amount Raised: $16,500,000
Applied Minerals

New York, New York, United States

Applied Minerals produces halloysite clay with commercially consistent product grades.

CommercialManufacturingMineral
Post Ipo EquityNov 7, 2014
Amount Raised: $2,000,000